Status:
UNKNOWN
Population Pharmacokinetics of Vancomycin, Meropenem, Milrinone, Dexmedetomidine and Fentanyl in Pediatric Patients During Extracorporeal Membrane Oxygenation
Lead Sponsor:
Yonsei University
Conditions:
Pediatric Patients Receiving Venoarterial Extracorporeal Membrane Oxygenation
Eligibility:
All Genders
Up to 18 years
Brief Summary
Extracorporeal membrane oxygenation (ECMO) has been used primarily in newborns since it was first successfully implemented in the 1970s, and has recently increased use in infants and young children. V...
Eligibility Criteria
Inclusion
- \<19 years old
- receiving VA ECMO in Severance Hospital, Yonsei University Health System.
- receiving one of these drugs: vancomycin or meropenem or milrinone or dexmedetomidine or fentanyl
- agreed to participate
Exclusion
- receiving drugs that could affect study drug's concentration due to drug-drug interaction
Key Trial Info
Start Date :
June 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04701099
Start Date
June 7 2020
End Date
April 1 2023
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Thoracic and Cardiovascular Surgery, Yonsei University Health System
Seoul, South Korea